Please login to the form below
Healthcare Glossary
Healthcare terms - Legal and regulatory affairs
- Abbreviated advertisement (UK)
- ABPI Code of Practice
- Adherence
- Boilerplate
- Commission on Human Medicines (CHM)
- Concordance
- Concordance programme
- Copyright
- Counterfeiting
- Data Protection Act
- Data sheet
- Economic evaluation
- Economic regulation
- Effectiveness
- European Foundation for Quality Management (EFQM)
- Generic medicine
- Guarantees and warranties
- Hypothesis
- Informed consent document
- Labelling
- Licensed
- Lobby
- National Readership Survey (NRS)
- Over the counter (OTC)
- Patent
- Prescribing information
- Prescription Medicines Code of Practice Authority (PMCPA)
- Registered trademark
- Reprint
- Royal Pharmaceutical Society of Great Britain (RPSGB)
- Trade allowance
- Trademark
- Unplanned cannibalisation
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- Environment: where does the pharmaceutical industry stand?
- ONS data reveals significant decrease in COVID-19 antibodies
- Novartis reports death of two patients treated with Zolgensma
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Are we the masters or servants of omnichannel engagement?
- JCVI publishes advice on COVID-19 vaccines ahead of autumn booster campaign
- AstraZeneca and Daiichi Sankyo’s Enhertu shows significant improvement for breast cancer patients
- Gilead Sciences announce positive results for Trodelvy in breast cancer patients
- UK government to launch national mission to tackle dementia
- WHO publishes first position paper on optimising brain health
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- Sanofi halts recruitment for trials assessing MS treatment
- Environment: where does the pharmaceutical industry stand?
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Avastin wins EU approval for advanced renal cancer
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
